Abstract | BACKGROUND: METHODS: RESULTS: CONCLUSIONS: These results indicate that WT161, as a selective HDAC6 inhibitor, is a promising agent against retinoblastoma.
|
Authors | Jun Sun, Xia Qian, Feifei Zhang, Xiaofeng Tang, Cheng Ju, Renfeng Liu, Ruihao Zhou, Zhiping Zhang, Xiao-Bin Lv, Changhua Zhang, Guofu Huang |
Journal | Translational cancer research
(Transl Cancer Res)
Vol. 8
Issue 8
Pg. 2759-2768
(Dec 2019)
ISSN: 2219-6803 [Electronic] China |
PMID | 35117033
(Publication Type: Journal Article)
|
Copyright | 2019 Translational Cancer Research. All rights reserved. |